Policy and Reimbursement Director Brenna Raines Discusses CMMI’s New Charge

Pharmaceuticals and Biotech Federal And State Policy Pharmaceuticals and Biotech

October 27, 2022

October 27, 2022, In an interview with AIS Health, ADVI’s Brenna Raines, director, policy and reimbursement, discusses the implications of an executive order, issued on October 14 by the Biden administration, directing the Centers for Medicare and Medicaid Services (CMS) Innovation Center (CMMI) to tackle drug costs. Read the full article here.


Reach out

Own your edge

We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.